U.S. stocks traded lower midway through trading, with the Nasdaq Composite dipping more than 500 points on Wednesday.
Merck's stock has surged 16.8% year-to-date, outpacing the Dow Jones. Keytruda remains a key growth driver, but patent expiration looms in 2028.
Dow Jones biotech giant Amgen, along with Nvidia stock and Coinbase Global, are in or near buy zones on the stock market today.
U.S. stocks traded mostly higher midway through trading, with the Nasdaq Composite gaining more than 100 points on Monday.
A healthy balance sheet is essential for supporting a growing payout. Chevron has a solid five-year plan that accounts for lower oil prices.
With a violent growth-to-value rotation hitting the stock markets, it can be tempted to ditch AI high-flyers and other frothy tech plays for the big blue chips. When it comes to time-tested blue chips, the Dow Jones Industrial Average is a good place to look.
Dow Inc. (DOW) concluded the recent trading session at $54.77, signifying a -1.16% move from its prior day's close.
Goldman Sachs and Apple were two of the worst-performing blue chip stocks on Thursday.
Dow Inc. (DOW) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
We have narrowed our search to five Dow stocks. These are: AMZN, AAPL, WMT, HON, JPM.
During times of turbulence and uncertainty in the markets, even when markets are at all-time highs, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
U.S. stocks traded mixed toward the end of trading, with the S&P 500 falling over 1% on Wednesday.